Atara Biotherapeutics Inc
F:AT2
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Atara Biotherapeutics Inc
F:AT2
|
US |
|
S
|
Sabina Gold & Silver Corp
F:RXC
|
CA |
|
T
|
TopBuild Corp
BMV:BLD
|
US |
|
F
|
Federated Hermes Inc
F:3KC
|
US |
|
Ironbark Zinc Ltd
ASX:SKM
|
AU |
|
L
|
Linde PLC
XMUN:LIN
|
UK |
|
ASR Nederland NV
F:A16
|
NL |
|
L
|
Lenzing AG
VSE:LNZ
|
AT |
|
Nitori Holdings Co Ltd
OTC:NCLTF
|
JP |
|
Taisei Corp
TSE:1801
|
JP |
|
E
|
Eaton Corporation PLC
XMUN:3EC
|
IE |
|
Tikehau Capital SCA
PAR:TKO
|
FR |
|
D
|
Deere & Co
DUS:DCO
|
US |
|
Groupon Inc
NASDAQ:GRPN
|
US |
|
SKF AB
F:SKFB
|
SE |
|
Vertiv Holdings Co
NYSE:VRT
|
US |
|
B
|
BlackBerry Ltd
XBER:RI1
|
CA |
|
Virgin Galactic Holdings Inc
F:0QL0
|
US |
|
S
|
Star Diamond Corp
SWB:GOC
|
CA |
Bankruptcy Probability
Atara Biotherapeutics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Atara Biotherapeutics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Atara Biotherapeutics Inc
NASDAQ:ATRA
|
103.4m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
444.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
195.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
156.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
126.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
65.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
50.2B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Atara Biotherapeutics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Atara Biotherapeutics Inc has total debt of 32.7m USD. This includes both short-term (0 USD) and long-term (32.7m USD) debt.
You can find a full breakdown on its Balance Sheet.
